We assessed associations between Vitamin D and development of statin-associated muscle symptoms (SAMS). Baseline Vitamin D and changes in Vitamin D with simvastatin did not predict SAMS. Clinical Vitamin D deficiency and insufficiency did not predict SAMS. Low Vitamin D was associated with transient increases in creatine kinase and pain. Future studies are needed to clarify the relationship between Vitamin D and SAMS.